ournal of Thoracic Oncology (JTO), the official Journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of thoracic malignancies. JTO emphasizes a multidisciplinary approach, and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces. The audience consists of epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonary specialists, radiologists, pathologists, and research scientists with a special interest in thoracic oncology.
Novel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnosed with non-small cell lung cancer, according to a new study published in the Journal of Thoracic Oncology.
May 19, 2023
0
18
Expanding the eligibility criteria for low-dose CT (LDCT) screening for lung cancer can increase the number of women and Black persons who can benefit from screening, according to a study published in the Journal of Thoracic ...
Oct 5, 2022
0
4
Implementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in the number of Stage I lung cancers detected and a 6.6 percent decrease in Stage IV disease, according to research ...
Sep 8, 2022
0
14
A new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation. The model may help speed ...
Aug 29, 2022
0
46
Research published in the Journal of Thoracic Oncology shows cytisine may be a safe and effective smoking cessation therapy in lung cancer screening volunteers.
Jul 28, 2022
0
1
Cancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the vaccines for patients treated for lung cancer with immune checkpoint inhibitors. Now, ...
Jun 22, 2022
0
23
Enrollment in lung cancer clinical trials declined 14 percent during the COVID-19 pandemic, according to research published in the Journal of Thoracic Oncology, the official journal of the International Association for the ...
Feb 17, 2022
0
2
The risk of death for patients with SARS-CoV-2 infection and thoracic cancer is based on seven major determinants, according to research published in the Journal of Thoracic Oncology, the official journal of the International ...
Feb 1, 2022
0
7
Patients with lung cancer who quit smoking after their diagnosis have a 29 percent improvement in their overall survival compared to patients who continue smoking after diagnosis, according to a study published in the Journal ...
Jan 4, 2022
0
23
Although the COVID-19 vaccines have been proven safe and effective in the general population, little is known about whether patients with lung cancer would develop a protective anti-spike antibody response because these patients ...
Nov 15, 2021
0
1
